Share
AACR Annual Meeting 2022
Ernest N. Morial Convention Center, New Orleans, Louisiana
April 08, 2022, at 3:00 PM ET - April 13, 2022, at 1:30 PM ETThe AACR Annual Meeting highlighted the best cancer science and medicine from institutions all over the world. Attendees were invited to stretch their boundaries, form collaborations, attend sessions outside their own areas of expertise, and learn how to apply exciting new concepts, tools, and techniques to their own research.
Unfortunately due to the recent developments regarding the SARS-CoV-2 pandemic, ATCC was not able to exhibit at the conference this year. However, we virtually presented a poster featuring our recent research on CAR-T target antigen luciferase reporter cell lines. Watch our poster presentation from the event and feel free to view some of our content around cancer diagnostics and drug development below.
Would you like to speak to one of ATCC’s representatives about a product or service? Make an appointment with us so we can discuss your needs.
Resources for cancer diagnostics and drug development
Luciferase-labeled cell lines
ATCC is bridging the gap between the in vitro and the in vivo by offering luciferase-labeled cell lines for biological mechanism studies and drug development; these advanced models provide a relatively simple, robust, and highly sensitive means to measure biological processes and to assess drug efficacy in live animal models through bioluminescence imaging.
Get started
Next-generation cancer models
ATCC is offering scientists a wide variety of next-generation patient-derived in vitro cancer models, including organoids, which will include both common as well as rare and understudied examples of cancer from numerous tissues. These advanced models are valuable tools to study cancer, identify and target novel therapies, and facilitate translational cancer research.
Discover how
EMT reporter cells
Epithelial-mesenchymal transition (EMT) and its reverse, MET, can play critical roles in promoting metastasis and invasion and contribute to drug resistance in carcinoma. ATCC used CRISPR gene editing to develop new reporter lines designed to enable the real-time monitoring of the changing status of cells from epithelial to mesenchymal.
Enhance your research
THP-1 reporter cells
ATCC offers luciferase reporters containing the response element of immunologically important transcription factors into the THP-1 cell line. These advanced models provide a robust and highly sensitive means to measure immune activation through in vitro bioluminescence.
Order THP-1 reporter cell lines
Cancer panels
ATCC offers a wide variety of cancer cell lines for use in research related to cancer genetics, early detection methods, and effective treatment of disease. Panels of these cell lines offer researchers the value of several lines for comprehensive studies. Explore our panels by tissue type, genetic mutation, or molecular signature.
Order cancer panels
Matched normal and cancer cells
Cancer research starts out with the investigation of the biological differences between normal, healthy cells and cancerous cells. That's why ATCC offers authenticated tumor-derived cell lines matched to normal cells from the same donor to provide you with a valuable starting point for your cancer studies.
Get the cells
hTERT-immortalized cells
Human telomerase reverse transcriptase (hTERT)–immortalized cells represent a breakthrough in cell biology research that combines the in vivo nature of primary cells with the traditional cell line's ability to survive continuously in vitro. Our collection encompasses a variety of cell types derived from human tissue.
Browse hTERT-immortalized cells
Isogenic cells
Clinically relevant cell models are critical for studies of molecular and cellular mechanisms of tumors, as well as for drug screening for cancer. With genome editing tools such as CRISPR/Cas9, ATCC has created isogenic cell lines with mutants of key oncogenes, which are ideal for elucidating molecular pathways of cancer progression.
Explore isogenic cells
Primary cells
Human primary cells more closely mimic the physiological state of cells in vivo and generate more relevant data representing living systems. ATCC Primary Cell Solutions consist of quality cells, reagents matched and optimized to work with each ATCC primary cell type, and trustworthy tips and techniques.
order primary cells
Human Cancer Models Initiative
ATCC is collaborating with the Human Cancer Models Initiative (HCMI) to offer scientists a wide variety of next-generation 2-D and 3-D patient-derived in vitro cancer models, including organoids.
ATCC is committed to making available a growing collection of models generated by the HCMI, which will include both common as well as rare and understudied examples of cancer from numerous tissues. These HCMI models are valuable tools to study cancer, identify and target novel therapies, and facilitate translational cancer research.
Find next-generation models
Check out our posters from previous AACR meetings
Poster
Primary NK Cells and Luciferase Expressing Reporter Cell Lines
This is a poster presented at AACR 2021 that explores the use of primary NK cells and luciferase reporter tumor cell lines in assay development.
More
Poster
Checkpoint Molecule Profiling in Tumor Cell Lines and Immune Cell Lines
This is a poster presented at AACR 2021 that explores the use of established cell lines and primary T cells in immune checkpoint assay development.
More
Poster
Development of a Novel ECAD-EmGFP Reporter Line for Pancreatic Cancer MET Study and Drug Discovery
This is a poster presented at AACR 2020 that discusses the use of the PANC-1 ECAD-EmGFP reporter line in studying epithelial-to-mesenchymal transition.
MoreAACR Annual Meeting
Your ATCC sales representative stands ready to discuss your research needs and provide you with personalized care. Please complete our form to let us know how we can help, and we will start working on your needs right away.
